Filing Flows

Filing Flows › Strata Critical Medical (SRTA) › Q1 2026

Strata Critical Medical (SRTA) Q1 2026 earnings results (first quarter 2026)

10-Q filed May 6, 2026

Strata Critical Medical (SRTA) reported revenue of $67.4M for the first quarter 2026 (Q1 2026), +87% from a year earlier and +0.9% from the quarter before. Operating margin was -4.4%, net earnings $2.2M (3.2% of revenue).

Revenue$67.4M
Year over year+87%
Quarter over quarter+0.9%
Operating margin-4.4%
Net earnings$2.2M

Strata Critical Medical, Q1 2026: revenue $67.4M (+87% year over year), operating margin -4.4%, net earnings $2.2M, operating cash flow $3.9M. The chart follows the revenue to costs, profit and cash.

Q1 2026AmountQ/QY/Y
Revenue$67.4M+0.9%+87%
Operating profit−$3.0M——
Net earnings$2.2M——
Operating cash flow$3.9M——

What changed

Revenue was $67.4M in Q1 2026, up 87% year over year and up 1% from the previous quarter. Logistics was the largest line at 71% of revenue. Logistics added $11.7M year over year (up 32%), 37% of the total change.

Gross margin was 21.0%, up 1.3 points from Q1 2025. Operating costs exceeded revenue by $3.0M, an operating margin of -4.4%. Operating expenses grew 34% against revenue growth of 87%. The fastest-growing cost line was Other operating costs (+264%). Net earnings were $2.2M. The effective tax rate was 0.0%. Non-operating items added $5.1M, 238% of pre-tax earnings, so the bottom line overstates operating performance.

Operating cash flow was $3.9M, 180% of net earnings. Non-cash charges added back $3.1M of depreciation and amortization and $5.0M of share-based compensation. Working capital and other items used $6.4M. Capital expenditures of $5.2M exceeded it, leaving free cash flow of −$1.3M.

Questions

What was Strata Critical Medical's revenue in the first quarter 2026?

Strata Critical Medical (SRTA) reported revenue of $67.4M for the first quarter 2026 (Q1 2026), +87% from a year earlier and +0.9% from the quarter before.

Was Strata Critical Medical profitable in the first quarter 2026?

Operating loss was $3.0M (-4.4% of revenue) and net earnings $2.2M.

Open the interactive Sankey →

Source: Strata Critical Medical 10-Q on SEC EDGAR.